198 related articles for article (PubMed ID: 17522386)
21. Prominent phenotypic variability associated with mutations in Progranulin.
Kelley BJ; Haidar W; Boeve BF; Baker M; Graff-Radford NR; Krefft T; Frank AR; Jack CR; Shiung M; Knopman DS; Josephs KA; Parashos SA; Rademakers R; Hutton M; Pickering-Brown S; Adamson J; Kuntz KM; Dickson DW; Parisi JE; Smith GE; Ivnik RJ; Petersen RC
Neurobiol Aging; 2009 May; 30(5):739-51. PubMed ID: 17949857
[TBL] [Abstract][Full Text] [Related]
22. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
van Swieten JC; Heutink P
Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of frontotemporal dementia patients with a Progranulin mutation.
Huey ED; Grafman J; Wassermann EM; Pietrini P; Tierney MC; Ghetti B; Spina S; Baker M; Hutton M; Elder JW; Berger SL; Heflin KA; Hardy J; Momeni P
Ann Neurol; 2006 Sep; 60(3):374-80. PubMed ID: 16983677
[TBL] [Abstract][Full Text] [Related]
24. The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.
Mackenzie IR; Rademakers R
Neurogenetics; 2007 Nov; 8(4):237-48. PubMed ID: 17805587
[TBL] [Abstract][Full Text] [Related]
25. Frontotemporal lobar degeneration: clinical and pathological relationships.
Snowden J; Neary D; Mann D
Acta Neuropathol; 2007 Jul; 114(1):31-8. PubMed ID: 17569065
[TBL] [Abstract][Full Text] [Related]
26. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
[TBL] [Abstract][Full Text] [Related]
27. Progranulin genetic variability contributes to amyotrophic lateral sclerosis.
Sleegers K; Brouwers N; Maurer-Stroh S; van Es MA; Van Damme P; van Vught PW; van der Zee J; Serneels S; De Pooter T; Van den Broeck M; Cruts M; Schymkowitz J; De Jonghe P; Rousseau F; van den Berg LH; Robberecht W; Van Broeckhoven C
Neurology; 2008 Jul; 71(4):253-9. PubMed ID: 18184915
[TBL] [Abstract][Full Text] [Related]
28. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.
Leverenz JB; Yu CE; Montine TJ; Steinbart E; Bekris LM; Zabetian C; Kwong LK; Lee VM; Schellenberg GD; Bird TD
Brain; 2007 May; 130(Pt 5):1360-74. PubMed ID: 17439980
[TBL] [Abstract][Full Text] [Related]
29. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
[TBL] [Abstract][Full Text] [Related]
30. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
[TBL] [Abstract][Full Text] [Related]
31. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.
van der Zee J; Rademakers R; Engelborghs S; Gijselinck I; Bogaerts V; Vandenberghe R; Santens P; Caekebeke J; De Pooter T; Peeters K; Lübke U; Van den Broeck M; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C; Dermaut B
Brain; 2006 Apr; 129(Pt 4):841-52. PubMed ID: 16495329
[TBL] [Abstract][Full Text] [Related]
32. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22.
Rosso SM; Kamphorst W; de Graaf B; Willemsen R; Ravid R; Niermeijer MF; Spillantini MG; Heutink P; van Swieten JC
Brain; 2001 Oct; 124(Pt 10):1948-57. PubMed ID: 11571213
[TBL] [Abstract][Full Text] [Related]
33. Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis.
Bigio EH; Johnson NA; Rademaker AW; Fung BB; Mesulam MM; Siddique N; Dellefave L; Caliendo J; Freeman S; Siddique T
J Neuropathol Exp Neurol; 2004 Aug; 63(8):801-11. PubMed ID: 15330335
[TBL] [Abstract][Full Text] [Related]
34. Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study.
Boeve BF; Baker M; Dickson DW; Parisi JE; Giannini C; Josephs KA; Hutton M; Pickering-Brown SM; Rademakers R; Tang-Wai D; Jack CR; Kantarci K; Shiung MM; Golde T; Smith GE; Geda YE; Knopman DS; Petersen RC
Brain; 2006 Nov; 129(Pt 11):3103-14. PubMed ID: 17030535
[TBL] [Abstract][Full Text] [Related]
35. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions.
Woulfe J; Kertesz A; Munoz DG
Acta Neuropathol; 2001 Jul; 102(1):94-102. PubMed ID: 11547957
[TBL] [Abstract][Full Text] [Related]
36. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.
Zarranz JJ; Ferrer I; Lezcano E; Forcadas MI; Eizaguirre B; Atarés B; Puig B; Gómez-Esteban JC; Fernández-Maiztegui C; Rouco I; Pérez-Concha T; Fernández M; Rodríguez O; Rodríguez-Martínez AB; de Pancorbo MM; Pastor P; Pérez-Tur J
Neurology; 2005 May; 64(9):1578-85. PubMed ID: 15883319
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.
Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A
Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624
[TBL] [Abstract][Full Text] [Related]
39. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.
Van Deerlin VM; Wood EM; Moore P; Yuan W; Forman MS; Clark CM; Neumann M; Kwong LK; Trojanowski JQ; Lee VM; Grossman M
Arch Neurol; 2007 Aug; 64(8):1148-53. PubMed ID: 17698705
[TBL] [Abstract][Full Text] [Related]
40. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
